checkAd

     583  0 Kommentare Bilkent City Hospital Selects Accuray's Radixact System - Seite 2

    About Accuray
    Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. The company's radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.

    Safe Harbor Statement
    Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to clinical applications, clinical results, patient experiences, patient outcomes and the company's ability to continue to penetrate the global radiation therapy market. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of the company's assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the company's ability to achieve widespread market acceptance of its products, including new product offerings, the company's ability to develop new products or enhance existing products to meet customers' needs, delays in the development or release of new offerings and such other risks identified under the heading "Risk Factors" in the company's quarterly report on Form 10-Q, filed with the SEC on February 8, 2019, and as updated periodically with the company's other filings with the SEC. 

    Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.

    Seite 2 von 3




    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Bilkent City Hospital Selects Accuray's Radixact System - Seite 2 Largest Hospital in Europe Expands Access to Precise Radiation Treatments to More Patients SUNNYVALE, California, March 15, 2019 /PRNewswire/ - Europe's largest hospital with 3,700 beds1, Bilkent City Hospital located in Ankara, selected Accuray …